Vanguard Global Advisers »

Aardvark Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 5.9k 3.77

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Polygon Management
Geode Capital Management
Silverarc Capital Management
Two Sigma Investments
State Street Corporation
UBS Group
AQR Capital Management
Millennium Management
Northern Trust

View all funds holding Aardvark Therapeutics